Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request

Search Results

Display Settings
Results per page: 10
Sort By: Relevance
Filter
  • 1-10 of  361 results for ""Immunotherapy""

Your Filters

Publication : bju international Filter by : Subject
Reset filters
Item request has been placed! ×
Item request cannot be made. ×
loading  Processing Request
Academic Journal

Stereotactic radiotherapy combined with immunotherapy or targeted therapy for metastatic renal cell carcinoma.

  • Authors : Kroeze SGC; Department of Radiation Oncology, University Hospital Zürich, University of Zurich, Zurich, Switzerland.; Fritz C

Subjects: Immunotherapy* ; Radiosurgery*; Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*therapy

  • Source: BJU international [BJU Int] 2021 Jun; Vol. 127 (6), pp. 703-711. Date of Electronic Publication: 2020 Nov 19.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

CMTM6 expression as a potential biomarker for immunotherapy in metastatic renal cell carcinoma.

  • Authors : Tulchiner G; Department of Urology, Medical University Innsbruck, Innsbruck, Austria.; Brunner A

Subjects: Immunotherapy*; Biomarkers, Tumor/Biomarkers, Tumor/Biomarkers, Tumor/*biosynthesis ; Carcinoma, Renal Cell/Carcinoma, Renal Cell/Carcinoma, Renal Cell/*metabolism

  • Source: BJU international [BJU Int] 2021 Jul; Vol. 128 (1), pp. 29-32. Date of Electronic Publication: 2021 Feb 07.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Adjuvant immunotherapy in renal cell carcinoma: a systematic review and meta-analysis.

  • Authors : Riveros C; Department of Urology, Houston Methodist Hospital, Houston, TX, USA.; Huang E

Subjects: Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/Carcinoma, Renal Cell*/drug therapy ; Kidney Neoplasms*/Kidney Neoplasms*/Kidney Neoplasms*/drug therapy; Humans

  • Source: BJU international [BJU Int] 2023 May; Vol. 131 (5), pp. 553-561. Date of Electronic Publication: 2023 Feb 28.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

The promise and challenges of neoadjuvant immunotherapy in the management of non-metastatic muscle-invasive bladder cancer.

  • Authors : Janisch F; Department of Urology, Medical University of Vienna, Vienna, Austria.; Department of Urology, Medical University of Hamburg, Hamburg, Germany.

Subjects: Immunotherapy* ; Neoadjuvant Therapy*; Urinary Bladder Neoplasms/Urinary Bladder Neoplasms/Urinary Bladder Neoplasms/*therapy

  • Source: BJU international [BJU Int] 2020 Jun; Vol. 125 (6), pp. 753-755. Date of Electronic Publication: 2020 Feb 27.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Urothelial cancer: a narrative review of the role of novel immunotherapeutic agents with particular reference to the management of non-muscle-invasive disease.

  • Authors : Doyle E; Department of Oncology, Oxford Cancer and Haematology Centre, Oxford University Hospitals NHS Foundation Trust, Oxford, UK.; Crew J

Subjects: Immunotherapy* ; Urothelium*; Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/Antineoplastic Agents, Immunological/*therapeutic use

  • Source: BJU international [BJU Int] 2019 Jun; Vol. 123 (6), pp. 947-958. Date of Electronic Publication: 2019 Jan 22.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Contemporary outcomes of bladder carcinoma in situ treated with an adequate bacille Calmette-Guérin immunotherapy.

  • Authors : Subiela JD; Urooncology Unit, Department of Urology, Fundació Puigvert, Department of Surgery, Universitat Autònoma de Barcelona, Barcelona, Spain.; Oncological and Functional Bladder Pathology Unit, Department of Urology, Hospital Universitario Ramón y Cajal, Universidad de Alcalá, Madrid, Spain.

Subjects: Carcinoma in Situ*/Carcinoma in Situ*/Carcinoma in Situ*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/drug therapy ; Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/Urinary Bladder Neoplasms*/pathology

  • Source: BJU international [BJU Int] 2022 Apr; Vol. 129 (4), pp. 542-550. Date of Electronic Publication: 2021 Aug 23.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Cytoreductive nephrectomy in the era of targeted therapies: a review.

Subjects: Cytoreduction Surgical Procedures* ; Immunotherapy* ; Nephrectomy*

  • Source: BJU international [BJU Int] 2017 Sep; Vol. 120 (3), pp. 320-328. Date of Electronic Publication: 2017 May 02.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Outcomes in patients with advanced urothelial carcinoma after discontinuation of programmed death (PD)-1 or PD ligand 1 inhibitor therapy.

  • Authors : Sonpavde G; UAB Comprehensive Cancer Center, Birmingham, AL, USA.; Pond GR

Subjects: Immunotherapy*; Antibodies, Monoclonal/Antibodies, Monoclonal/Antibodies, Monoclonal/*administration & dosage ; Antineoplastic Agents/Antineoplastic Agents/Antineoplastic Agents/*administration & dosage

  • Source: BJU international [BJU Int] 2017 Apr; Vol. 119 (4), pp. 579-584. Date of Electronic Publication: 2016 Oct 26.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
Editorial & Opinion

Immunotherapy in urological malignancies: can you take your knowledge to the next level?

Subjects: Immunotherapy/Immunotherapy/Immunotherapy/*trends ; Urologic Neoplasms/Urologic Neoplasms/Urologic Neoplasms/*drug therapy; Humans

  • Source: BJU international [BJU Int] 2016 Oct; Vol. 118 (4), pp. 491.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print Cited Medium: Internet ISSN: 1464-410X

Record details

Read Online Read More Add to Saved list
×
Academic Journal

Immune checkpoint blockade - a treatment for urological cancers?

  • Authors : Elhage O; Medical Research Council (MRC) Centre for Transplantation, King's College London and Guy's Hospital, London, UK. .; Galustian C

Subjects: CTLA-4 Antigen/CTLA-4 Antigen/CTLA-4 Antigen/*antagonists & inhibitors ; Cell Cycle Checkpoints/Cell Cycle Checkpoints/Cell Cycle Checkpoints/*drug effects ; Cell Cycle Checkpoints/Cell Cycle Checkpoints/Cell Cycle Checkpoints/*immunology

  • Source: BJU international [BJU Int] 2016 Oct; Vol. 118 (4), pp. 498-500. Date of Electronic Publication: 2016 Aug 23.Publisher: Blackwell Science Country of Publication: England NLM ID: 100886721 Publication Model: Print-Electronic Cited Medium: Internet ISSN:

Record details

Read Online Read More Add to Saved list
×
  • 1-10 of  361 results for ""Immunotherapy""